Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Joanne L. Blum, David A. Smith et al.|Journal of Clinical Oncology|2009Cited by 245
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung MetastasesNancy Chan, Linda T. Vahdat, Amy D. Willis et al.|Clinical Cancer Research|2016Cited by 224